A2AR
Showing 1 - 25 of >10,000
Chronic Coronary Syndromes Trial in Marseille (blood samples)
Recruiting
- Chronic Coronary Syndromes
- blood samples
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Dec 20, 2021
Acute Coronary Syndrome Trial in Marseille (blood samples)
Completed
- Acute Coronary Syndrome
- blood samples
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Oct 11, 2021
Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- AR-14034 SR implant lower dose
- +3 more
- (no location specified)
Mar 3, 2023
Gout, Arthritis, Gouty, Hyperuricemia Trial in Phoenix, Tucson, Myrtle Beach (AR882 Dose 1, AR882 Dose 2, Allopurinol Tablet)
Not yet recruiting
- Gout
- +3 more
- AR882 Dose 1
- +2 more
-
Phoenix, Arizona
- +2 more
Jul 13, 2022
Nursing Education Trial in Seoul (AR guidance with Hololens 2)
Completed
- Nursing Education
- AR guidance with Hololens 2
-
Seoul, Korea, Republic ofSamsung Medical Centre
Jun 30, 2022
Type 2 Diabetes Trial in Nanjing (AR group: aerobic training before resistance training, RA group: resistance exercise before
Recruiting
- Type 2 Diabetes
- AR group: aerobic training before resistance training
- RA group: resistance exercise before aerobic exercise
-
Nanjing, Jiangsu, ChinaMaigaoqiao Community Health Service Center
Nov 17, 2023
Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial
Not yet recruiting
- Hormone Receptor-positive Breast Cancer
- +2 more
-
Nashville, TennesseeSarah Cannon Research Institute
Oct 5, 2022
Amputation, Upper Limb Trial in Edmonton (MyoTrain AR, Motor Imagery)
Recruiting
- Amputation
- Upper Limb
- MyoTrain AR
- Motor Imagery
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jul 27, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in United States (AR-13503 Implant 10.6 Dose,
Completed
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- AR-13503 Implant 10.6 Dose
- +3 more
-
Gilbert, Arizona
- +5 more
Jun 9, 2022
Gout, Arthritis, Gouty, Hyperuricemia Trial in Australia, Taiwan, United States (AR882 Dose 1, AR882 Dose 2, Placebo)
Completed
- Gout
- +3 more
- AR882 Dose 1
- +2 more
-
Gilbert, Arizona
- +22 more
Jan 30, 2023
Aging Trial in Glendale
Withdrawn
- Aging
- (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
- Control
-
Glendale, ArizonaGlencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023
Ventilator Associated Pneumonia, Staphylococcus Aureus Trial in Limoges (Suvratoxumab, Placebo)
Recruiting
- Ventilator Associated Pneumonia
- Staphylococcus Aureus
- Suvratoxumab
- Placebo
-
Limoges, FranceResearch Site
Feb 1, 2023
Dry Eye Disease Trial in United States (AR 15512 Ophthalmic Solution, Vehicle)
Recruiting
- Dry Eye Disease
- AR 15512 Ophthalmic Solution
- Vehicle
-
Torrance, California
- +19 more
Dec 9, 2022
Obesity, Morbid, Bariatric Surgery, Adolescent Trial in Aurora (Phentermine, Immediate Release Topiramate, Placebo for
Completed
- Obesity, Morbid
- +4 more
- Phentermine
- +3 more
-
Aurora, ColoradoChildren's Hospital Colorado
Mar 7, 2022
Diarrhea Trial in Silver Spring (Invaplex[AR-DETOX], Placebo)
Completed
- Diarrhea
- Invaplex[AR-DETOX]
- Placebo
-
Silver Spring, MarylandWalter Reed Army Institute of Research Clinical Trials Center (W
Jul 7, 2021
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Diabetes Type 2 With Periodontal Disease Trial in Tainan (AR Dental Care Training System)
Recruiting
- Diabetes Mellitus Type 2 With Periodontal Disease
- AR Dental Care Training System
-
Tainan, TaiwanChimei Medical Center
Aug 7, 2023
Cystic Fibrosis Trial in United States (Inhaled AR-501, Inhaled Placebo)
Recruiting
- Cystic Fibrosis
- Inhaled AR-501
- Inhaled Placebo
-
Tucson, Arizona
- +21 more
Apr 12, 2022
SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor
Completed
- SARS-CoV-2 (COVID-19) Infection
- Advanced or Metastatic Hematological or Solid Tumor
- Autophagy inhibitor (GNS651)
- +3 more
-
Lyon, Rhône, France
- +11 more
Sep 29, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023
Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)
Active, not recruiting
- Circulating Tumor Cell
- Metastatic Prostate Cancer
- Cabazitaxel
- +4 more
-
Delft, Netherlands
- +8 more
Aug 19, 2021
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy
Not yet recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Pharmacotherapy Discontinuation
- +3 more
- (no location specified)
Feb 11, 2022